Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Breast Neoplasms (Phase 1/Phase 2)
Cholangiocarcinoma (Phase 2)
Gallbladder Neoplasms (Phase 1/Phase 2)
Healthy Volunteers (Phase 1)
Mutation (Phase 2)
Neoplasms (Phase 1/Phase 2)
Prostatic Neoplasms (Phase 1/Phase 2)
Receptors, Fibroblast Growth Factor (Phase 2)
Sarcoma (Phase 1/Phase 2)
Small Cell Lung Carcinoma (Phase 1/Phase 2)
Stomach Neoplasms (Phase 1/Phase 2)
Thyroid Neoplasms (Phase 1/Phase 2)
Triple Negative Breast Neoplasms (Phase 1/Phase 2)
Urinary Bladder Neoplasms (Phase 1/Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue